Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    19114612 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes
Interventions: Drug: dapagliflozin;   Drug: placebo;   Drug: metformin
2 Completed Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
Condition: Type2 Diabetes Mellitus
Interventions: Drug: Saxagliptin;   Drug: Placebo for Saxagliptin
3 Not yet recruiting Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
Condition: Diabetes Mellitus, Type II
Interventions: Drug: triple combination therapy;   Drug: Stepwise add-on therapy

Study has passed its completion date and status has not been verified in more than two years.